VS
When evaluating costs, MEDX features a management fee (MER) of 0.4%, compared to 0.08% for ZSP. Performance-wise, MEDX has returned 7.18% year-to-date with -$0 M in net flows, whereas ZSP is at 14.37% with +$458 M. Use the comparison tool below to benchmark these funds across top 10 holdings, yield, sector weights and historical returns.
NAV Performance and Flows
Key Data
Compare
MEDX
ZSP
| AuM | $2.36 M | $24,506.28 M |
| Management Fees | 0.40% | 0.08% |
| Exp. ratio | 0.40% | 0.09% |
| Tracking Difference | -0.58% | -0.25% |
Historical performance and flows
As of September 3, 2026
| 1M | 3M | YTD | 1Y | 3Y | ||
|---|---|---|---|---|---|---|
| Perf. | MEDX | +4.60% | +15.33% | +7.18% | +17.55% | - |
ZSP | -1.76% | +1.99% | +14.37% | +21.17% | +79.58% | |
| Flows | MEDX | -$1 M | -$0 M | -$0 M | -$0 M | - |
ZSP | +$63 M | +$125 M | +$458 M | +$892 M | +$5,270 M |
MEDX vs ZSP exposure
Countries
MEDX
Exposure data will be available soon
ZSP
USA
96.51%
Sectors
MEDX
Exposure data will be available soon
ZSP
Technology
44.85%
Finance
14.06%
Healthcare
8.98%
Consumer Non-Cyclicals
8.97%
Industrials
7.63%
Other
15.53%
As of September 3, 2026
Top 10 Holdings
MEDX
Exposure data will be available soon
ZSP
Apple, Inc.
7.66%
NVIDIA Corp.
7.39%
Microsoft Corp.
5.24%
Amazon.com, Inc.
3.61%
Alphabet, Inc.
3.07%
Broadcom Inc.
2.88%
Alphabet, Inc.
2.47%
Meta Platforms, Inc.
1.85%
Micron Technology, Inc.
1.55%
JPMorgan Chase & Co.
1.47%
Diversification
MEDX
Exposure data will be available soon
ZSP
Total weight of top 10 holdings out of 502 total
37.19%
Characteristics
Compare
MEDX
ZSP
| Provider | Global X | BMO |
| Management | Passively managed | Passively managed |
| Benchmark | VettaFi Equal Weight Global Healthcare NTR Index - CAD | S&P 500 CAD Total Return Index - CAD |
| Replication Method | Direct (Physical) | Direct (Physical) |
| Asset Class | Equity | Equity |
| Dividend Policy | Distributing | Distributing |
| Trailing 12m distribution yield | 1.41% | 0.76% |
| Meets ESG criteria | No | No |
| Inception Date | April 30, 2025 | November 14, 2012 |
Frequently asked questions about MEDX and ZSP
Which ETF has performed better year to date: MEDX or ZSP?
As of September 3, 2026, MEDX has returned 7.18% year to date, while ZSP has returned 14.37%. ZSP is ahead on YTD performance.
Which ETF is larger by assets under management: MEDX or ZSP?
As of September 3, 2026, MEDX manages $2.36 M in assets, while ZSP manages $24.51 B. ZSP is the larger fund by AUM.
How are MEDX and ZSP managed?
MEDX is passively managed by Global X. It tracks the VettaFi Equal Weight Global Healthcare NTR Index - CAD benchmark. ZSP is passively managed by BMO. It tracks the S&P 500 CAD Total Return Index - CAD benchmark.
Which ETF is attracting more investor flows: MEDX or ZSP?
Year to date, MEDX has seen -$0.08 M in net flows, compared with +$457.96 M for ZSP. ZSP has attracted more net investor money so far.
How do the fees of MEDX and ZSP compare?
MEDX has an expense ratio of 0.40%, while ZSP has an expense ratio of 0.09%.
Recent articles about MEDX and ZSP
A Guide to Active vs Passive ETFs for Canadian Investors
Discover the difference between active and passive ETFs in this comprehensive guide. Learn about their strategies, advantages, drawbacks, and how to combine both for a balanced investment approach.
Posted on 7/19/2023 by Tony Dong inETF Ecosystem
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.